Thrombolysis in the Management of Lower Limb Peripheral Arterial Occlusion—A Consensus Document fn1fn1This study was supported in part by Abbott Laboratories, Abbott Park, Illinois; Behringweike AG, Marburg, Germany; Boehringer Ingelheim UK, Bracknell, Berkshire, United Kingdom; Boehringer Mannheim AG, Mannheim, Germany; Genentech, Inc., South San Francisco, California; and Knoll AG, Ludwigshafen, Germany. This study was endorsed by the Cardiovascular and Interventional Radiological Society of Europe, Brussels, Belgium; the European Society for Vascular Surgery, Milan, Italy; the Internal Society for Thrombosis and Hemostasis, Chapel Hill, North Carolina; the International Union of Angiology, Lisbon, Portugal; and the Society of Cardiovascular and Interventional Radiology, Fairfax, Virginia.aaDisclaimer: This Consensus Document deals with the use of thrombolytic therapy in the management of lower limb ischemia. Much of the discussion centers on published data. However, it is recognized that in clinical practice each case must be considered on its own merits, and that there may be good clinical reasons for adopting a different approach from those included in these guidelines. Participating societies and individuals wish to emphasize that the comments and recommendations in this Document should be taken as a whole and do not necessarily represent the only correct approach to the treatment of individual patients.